Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or nonsquamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

被引：0

作者：

Santin, A. ^{[1
]}

Patricia, G. ^{[2
]}

Sill, M. ^{[3
]}

McMeekin, D. ^{[4
]}

Leitao, M. ^{[5
]}

Brown, J. ^{[6
]}

Sutton, G. ^{[7
]}

Van Le, L. ^{[8
]}

Boardman, C. ^{[9
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT USA

[2] Upstate Carolina CCOP, Spartanburg, SC USA

[3] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[4] Univ Oklahoma, Oklahoma City, OK USA

[5] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] St Vincent Hosp, Indianapolis, IN USA

[8] Univ N Carolina, Sch Med, Chapel Hill, NC USA

[9] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA

来源：

关键词：

D O I：

10.1016/j.ygyno.2010.12.047

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S18 / S18

页数：1